
Twist Bioscience Investor Relations Material
Latest events

Q2 2025
Twist Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Twist Bioscience Corporation
Access all reports
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. It offers synthetic DNA-based tools for research and development applications in life sciences. The company also provides molecular biology solutions comprising molecular cloning, next generation sequencing libraries, protein expression, and gene synthesis solutions; cytometry solutions; and biologics solutions for preclinical study. It serves the biotechnology research, pharmaceuticals and drug discovery, diagnostics, chemical manufacturing, agriculture industries, as well as contract research organizations and academic institutions.
Key slides for Twist Bioscience Corporation


Q2 2025
Twist Bioscience Corporation


Q2 2025
Twist Bioscience Corporation
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
TWST
Country
🇺🇸 United States